Psyence Group Inc. (CSE:PSYG)

Market Cap	2.19M
Revenue (ttm)	n/a
Net Income (ttm)	-13.36M
Shares Out	15.64M
EPS (ttm)	-1.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,900
Average Volume	5,659
Open	0.1600
Previous Close	0.1400
Day's Range	0.1600 - 0.1600
52-Week Range	0.0989 - 0.2476
Beta	1.27
RSI	23.94
Earnings Date	Sep 4, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, c...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PSYG